share_log

ティムスがランクイン、急性腎障害治療薬候補の第1相臨床試験で第1例目の投与実施

Tim's has ranked in, and the first administration was conducted in the first phase clinical trial of a treatment candidate for acute renal dysfunction.

Fisco Japan ·  Jun 20 09:38

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment